Procedural characteristics and clinical outcomes in patients undergoing percutaneous coronary intervention for left

David E Kandzari1, Anthony H Gershlick, Patrick W Serruys

  • 1Piedmont Heart Institute, Atlanta, GA, USA.

Insights

Percutaneous coronary intervention (PCI) for distal left main trifurcation disease showed similar procedural and five-year clinical outcomes compared to bifurcation disease. These findings support PCI for selected trifurcation cases.

Area of Science:

  • Interventional Cardiology
  • Cardiovascular Research
  • Medical Device Technology

Background:

  • Distal left main (LM) trifurcation disease presents unique challenges for percutaneous coronary intervention (PCI).
  • Limited data exist on procedural and clinical outcomes for PCI in distal LM trifurcation versus bifurcation lesions.

Purpose of the Study:

  • To compare procedural methods and early/late clinical outcomes of distal LM trifurcation PCI versus bifurcation PCI.
  • To evaluate the safety and efficacy of everolimus-eluting stents in treating distal LM trifurcation disease within the EXCEL trial.

Main Methods:

  • Retrospective analysis of patients from the EXCEL trial with distal LM disease.
  • Categorization of patients into those with trifurcation versus bifurcation anatomy.
  • Comparison of angiographic, procedural characteristics, and five-year clinical events (death, myocardial infarction, stroke, revascularization, stent thrombosis).

Main Results:

  • Out of 605 patients with distal LM disease, 61 (10.1%) had trifurcation anatomy.
  • Five-year primary composite endpoint rates were similar: 16.6% for trifurcation vs. 22.5% for bifurcation (p=0.32).
  • Ischemia-driven revascularization (11.9% vs. 12.0%, p=0.94) and stent thrombosis (1.7% vs. 2.3%, p=0.76) rates were also comparable.

Conclusions:

  • PCI using everolimus-eluting stents for distal LM trifurcation disease demonstrated similar procedural and long-term outcomes compared to bifurcation disease.
  • These results support PCI as a viable treatment strategy for carefully selected patients with distal LM trifurcation disease.
  • The findings contribute to understanding treatment options for complex coronary artery disease involving the distal LM.
Abstract

Related Concept Videos

Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
504
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
173
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
921